Rethinking DCIS: A Conversation with Dr. Kornelia Polyak
Sometimes referred to as stage 0 breast cancer, ductal carcinoma in situ (DCIS) is a noninvasive growth of abnormal...
Category: Meetings
Sometimes referred to as stage 0 breast cancer, ductal carcinoma in situ (DCIS) is a noninvasive growth of abnormal...
Most breast cancers express the estrogen and/or progesterone hormone receptors, which fuel tumor growth upon engagement with their respective...
Guest post by the Biopharma Collaborative Core Team In 2019, AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) embarked...
About 80 percent of breast cancers express the estrogen receptor (ER). In ER-positive tumors, estrogen is the main driver...
From a joyous opening performance from the Preservation Hall All-Stars to a closing plenary that highlighted the full spectrum...
Although childhood cancer is rare, it represents the leading cause of death by disease in children in developed countries....
From June 23-26, researchers from around the world will gather in Boston for the Third AACR International Meeting on...
As the first AACR Annual Meeting held in person after the pandemic was coming to a close, the last...
Since COVID-19 first began its siege on the world, much of our scientific knowledge about the disease—and its source...
For the past several decades, researchers have been harnessing the power of the immune system to fight cancer. They...